Cancer therapy goes to the next level: immune cells now activate anti-cancer drugs
Cancer CAR-T therapy SEAKER cells

Cancer therapy goes to the next level: immune cells now activate anti-cancer drugs

Dr. Michaela Diakatou
Dr. Michaela Diakatou

In 10 seconds? Engineered immune T cells (CAR-T cells) have been a game-changer in cancer treatment. Now, scientists took this type of therapy to the next level: they equipped these immune cells with the extra ability to activate anti-cancer drugs.

Can you remind me what is CAR-T therapy? CAR-T therapy programs T cells to attack cancer. T cells are usually taken from the patient’s samples and engineered to express a synthetic molecule called a Chimeric Antigen Receptor (CAR). Thanks to this receptor, CAR-T cells can recognize and bind proteins on the surface of cancer cells and then kill those cells.

Get unlimited access to our 3-min Digests and other premium features!

Choose your plan.

Sparrow Insiders

$0 (Limited Offer)
  • Receive our daily Digest in your inbox
  • Created & reviewed by real scientists
  • Preview 380+ Digests in our library
  • Upgrade for unlimited learning
  • Unsubscribe anytime
  • Subject to availability
Join our first 25k subscribers for free! Signup Progress Bar Subscribe now for free

Sparrow Unlimited

$19 / month
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now

Sparrow Unlimited

$99 / year
  • One easy payment - save 56%
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now